HealthEdge Acquires Legacy-Xspire Holdings, LLC

December 18, 2019

HealthEdge Investment Partners, a Tampa-based healthcare-focused private equity firm, completed an acquisition of Legacy-Xspire Holdings, LLC, a Ridgeland, Mississippi-based branded and generic pharmaceutical marketing and distribution platform, on December 18, 2019. The deal adds a pharmaceutical marketing and distribution capability (combining WraSer Pharmaceuticals, Gentex Pharma, and Xpsire Pharma) to HealthEdge's portfolio to support organic growth and product acquisitions across the U.S.

Buyers
HealthEdge Investment Partners, LLC
Targets
Legacy-Xspire Holdings, LLC
Industry
Pharmaceuticals
Location
Mississippi, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.